No insider purchase over the last 90 days. The latest was filed 16 Apr 2024.
Arkema, founded in 2004, is a Chemicals & Materials company based in Colombes, France. Its directors and officers file their transactions with AMF. In the past year (18 October 2025 to 18 October 2026), 11 filings came from 10 insiders.
There is no open-market purchase to report; the filings show 3 sales worth €5.1M by 3 insiders. At €2.8M, the sale published on 13 October 2026 by Fonds Stratégique de Participations Société par actions simplifiée is the largest of the period (0.068% of market cap).
The median gap between a trade and its publication by AMF is 7 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
For context, the typical company on the same exchange (median of 315 companies) published 6 filings over the same period, against 11 filings here. Over the whole record (from 2021), the tally stands at 9 purchases and 22 sales.
Other companies in the same sector with recent insider buying flagged by our signals: Culp Inc. This summary is built from AMF disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Arkema Hold (neutral), based on 14 analysts. Average price target: €62.36.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 115 declarations
Arkema is a leading French chemical group listed on Euronext Paris under ISIN FR0010313833. The company was created in 2006 following the spin-off of Total’s chemicals division, and it has since undergone a deliberate transformation toward specialty materials in order to reduce exposure to more cyclical commodity-style businesses. Arkema was listed in Paris in 2006, marking the beginning of its life as an independent industrial group. Since then, management has pursued a long-term portfolio shift supported by targeted investments and acquisitions in adhesives, advanced materials and coating-related solutions.
Today, Arkema’s activities are organized around three specialty materials pillars — Adhesive Solutions, Advanced Materials and Coating Solutions — which accounted for roughly 92% of group sales in 2024. The company also maintains an Intermediates segment, made up of more competitive but more cyclical businesses, whose share in the portfolio is expected to gradually decline. This structure reflects a clear strategic objective: to strengthen higher value-added, more innovative and more resilient businesses over time.
Arkema offers a broad range of products and solutions for diverse industrial end markets: high-performance adhesives through Bostik, advanced materials used in electrification, new energy systems, 3D printing, bio-based products and sports applications, as well as coating solutions for paints, performance coatings and related industrial uses. The group also highlights expertise in bio-based materials, recycling and the circular economy, which are central themes in its innovation and growth strategy.
From a financial perspective, Arkema has reached meaningful scale, with 2024 sales of €2.722 billion in Adhesive Solutions and €3.562 billion in Advanced Materials, underscoring the growing contribution of specialty businesses to the group’s profile. Profitability in these segments remains above that of the intermediates businesses, supporting the strategic logic of the portfolio shift. Arkema has a global industrial and commercial footprint, with a strong presence in Europe, North America and Asia, and operates numerous production sites, research centers and commercial teams worldwide. The company also emphasizes innovation, with new patents filed each year and sustainability embedded in its long-term development model.
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 2 filings published between 13 October and 16 October 2026: 2 sales for €4.7M. Largest amounts: Fonds Stratégique de Participations Société par actions simplifiée (administrateur), sales of €2.8M; Fonds Stratégique de Participations SAS (administrateur), sales of €1.8M.
Recent news
Foot National published an article on 3 October 2026 titled "Arkema Première Ligue : les résultats complets et le classement après la quatrième journée" (headline in French).
Headline published by L'Équipe on 3 October 2026: "Lyon (F) 5-0 Toulouse (F), Arkema Première Ligue (F) : match terminé" (headline in French).
Under the headline "Le Havre (F) 2-0 Saint-Malo (F), Arkema Première Ligue (F) : match terminé", L'Équipe published an article on 3 October 2026 (headline in French).
Headlines quoted as published, with source and date. The gap to insider purchases is computed from the filings and implies no link between the article and the purchase. Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 17 October 2026 (UTC)
Headquarters: Colombes, France · Founded: 2004 · 19,779 employees (2017) · Wikipedia article
Source: Wikidata (CC0).